Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Tykerb studied in phase III trial for head and neck cancer

March 2, 2007

Davanat filed for E.U. orphan drug status, advancing in phase II trials

March 2, 2007

Fenretinide receives orphan drug designations in U.S. and E.U.

March 2, 2007

Alpharadin improves survival in hormone-refractory prostate cancer

March 2, 2007

Addition of oblimersen to docetaxel may not be beneficial in advanced prostate cancer

March 2, 2007

AT-101 monotherapy induces responses in hormone-refractory prostate cancer

March 2, 2007

New therapeutic agents for cancer covered in recent patents

March 2, 2007

Cellular and molecular targets in tumor microenvironment considered for chemoprevention

March 1, 2007

Abiraterone active in androgen-independent, castration refractory prostate cancers

March 1, 2007

DMXAA increases efficacy of docetaxel in hormone-refractory prostate cancer

March 1, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...